Reply to comment
what are you talking about?
August 5, 2008 by Anonymous, 1 year 15 weeks ago
Comment id: 31386
Reply
About us
Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.Recommended
Andrew Sullivan Dan Sullivan Doug Arellanes Emmanuelle Richard Faith Sullivan Fred Bortz Heather Havrilesky Henry Copeland Kate Sullivan Ken Layne lagreenbean.com LAist.com Maggie Sullivan Matt Welch NewYorkology Opinion L.A. Ron Kaye Slashdot Steve Elzer & Family TheNewsroom.org Thor Garcia Tony Pierce Wonkette OlderThanks CNET for naming Science Blog one of your Blog 100!
hiv uses a glycoprotein on its surface called gp120 to form bonds with cd4.
it can use the co receptors ccr5 or cxcr4 or cxcr5 to do bond its gp120 to.
the object of this therapy is to remove the gp120 from hiv.
see?
its basically like taking the sharp teeth out of an attack dog.
i dont know what the hell your talking about. this therapy has nothing to do with ccr5. its not inhibiting it at all. its more like
gp120 inhibiting.
>_>